Encapsulation of an antifungal agent within biodegradable polymers: composition effect by Yammine, Paolo et al.
    ISSN 2321-807X 
4274 | P a g e                                                       J a n u a r y  2 9 ,  2 0 1 6  
Encapsulation of an antifungal agent within biodegradable polymers: 
composition effect
Rima Kassab1, Dima Moussa1, Paolo Yammine*1 
1
Department of Chemistry, Faculty of Sciences, University of Balamand, Tripoli, Lebanon 
rima.kassab@balamand.edu.lb 
dima.moussa@balamand.edu.lb 
paolo.yammine@balamand.edu.lb 
*Corresponding author: paolo.yammine@balamand.edu.lb 
ABSTRACT 
Polylactic acid and poly(lactic-co-glycolic acid) are two aliphatic polyesters commonly used in drug delivery systems. 
Having a hydrophobic nature, they could be used for the encapsulation of hydrophobic drugs such as Amphotericin B. 
Drug-loaded microspheres were prepared using solvent evaporation by changing the ratio of Polylactic acid to poly(lactic-
co-glycolic acid) in the organic mixture. Results showed that higher drug encapsulation and drug loading values were seen 
for formulations having higher lactide content. This had also influenced the drug release rate which was slower at higher 
lactide percentage. Microspheres, which were spherical in shape and porous in structure, had homogeneous particles 
sizes ranging between 100 and 300 µm. At last, FT-IR spectra recorded in this study revealed a stable character of both 
polymer and drug after microencapsulation. 
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1.  INTRODUCTION  
Much research has been focused recently on using biodegradable polymeric microspheres as novel drug delivery 
systems. Thermoplastic aliphatic polyesters such as Polylactic acid (PLA) and poly(lactic-co-glycolic acid) (PLGA) are 
most commonly used in these applications owing to their biodegradability, biocompatibility, mechanical strength, and non-
toxicity[1-4] (Figure 1). Medical uses of these polymers in drug delivery involve the microencapsulation of small dug 
molecules as well as large biomolecules as proteins, peptides, and DNA/RNA[5-9]. 
(a) (b) 
Fig 1: Structures of (a) PLA where n is the number of units of lactic acid and (b) PLGA where x and y and number 
of units of lactic acid and glycolic acid respectively [6] 
 
With new diseases and infections emerging worldwide, the work in the medical field is concentrating on finding suitable 
drug treatment methods that are highly effective and less costing. Among these, the hydrophobic small drug molecules 
constitute a significant class which could be extremely helpful in polymeric delivery systems. However, their use poses a 
great challenge in order to reach the best encapsulation and release rates. These characteristics are affected by several 
factors such as drug properties, its solubility in aqueous and organic media, its stability in vivo, and drug-polymer 
interactions [10].  
Routes of drug administration mainly depend on drug properties in addition to the type of delivery system. Yet, the oral 
route of administration remains the most commonly used, since it is simple, painless, and dosing of the medication can be 
easily adjusted or terminated [10,11]. Drug delivery systems prepared to be used in oral administration must enable the 
protection of the drug from enzymatic degradation and remaining body organs from undesirable side effects. 
Many studies have been done to encapsulate hydrophobic drugs in polymeric microspheres of PLA and PLGA. These 
could be prepared by different methods, among which, the emulsion solvent evaporation technique is the most 
widespread. However, there are several preparative variables that could affect drug encapsulation and release rates 
obtained; most importantly the drug solubility within the polymeric mixture [12]. 
Amphotericin B (AmB), an antifungal hydrophobic drug, is chosen as a model drug to be encapsulated in polymeric 
microspheres of PLA and PLGA. This is done by changing the ratio of lactide and glycolide content in the polymeric 
mixture to evaluate the resulting effects on prepared microspheres.f drug content, particle size, morphology, interaction 
between drug and polymer, stability, drug release and cytotoxicity. 
2.  EXPERIMETAL 
2.1. Materials 
The drug Amphotericin B, the polymers Poly(DL-lactide) (MW 75,000-120,000) and poly(lactic-co-glycolic acid) 
(lactide:glycolide 50:50, MW 30,000-60,000), the surfactant tween 80, and Phosphate Buffered Saline (PBS) (0.2 M, pH 
7.4) are purchased from Sigma-Aldrich, Chemie Germany. The solvents Dichloromethane (DCM) and Methanol (MeOH) 
are of analytical grade. 
2.2. Methods 
AmB-loaded PLA and PLGA microspheres were synthesized using o/w emulsion solvent evaporation method. It consisted 
on preparing different microspheres formulations by varying the ratios of PLA and PLGA each time in the polymeric 
mixture and fixing the quantity of drug used, as shows Table 1. This was done to check the effect of lactide and gycolide 
content, in addition to the effect of drug solubility in this polymer solution on drug encapsulation and release. 
Typically, 500 mg of polymer mixture containing PLA and PLGA at different ratios and 70 mg drug were dissolved in an 
organic solution of 14:6 ml DCM:MeOH. This organic phase was added to an aqueous phase containing the surfactant 
Tween 80. The whole mixture was stirred for 6 hours at 1400 rpm using a mechanical stirrer to allow solvent evaporation 
and microspheres formations. These were collected by filtration after washing with water and methanol, finally oven dried. 
 
 
 
 
 
    ISSN 2321-807X 
4276 | P a g e                                                       J a n u a r y  2 9 ,  2 0 1 6  
Table 1. Ratios of PLA and PLGA in the polymeric mixture 
Formulation 
Code 
Polymer Mixture 
PLA:PLGA (mg) 
F1 500 :0 
F2 400 :100 
F3 250 :250 
F4 100 :400 
F5 0 :500 
 
Following microencapsulation, the prepared microspheres were characterized for: 
- Drug Encapsulation (%DE) and Drug Loading (%DL): Microspheres are dissolved in 7/3 ml DCM/MeOH and 
the drug content of each formulation is measured by UV/Vis Sectrophotometry (Microplate Spectrophotometer, 
Epoch Biotek, USA) at 409 nm. The percentage drug entrapment (%DE) and drug loading (%DL) are calculated 
as follows: 
%DE = 
mass drug Introduced
mass drug edEncapsulat
*100 
%DL = 
mass esMicrospher
mass drug edEncapsulat
*100 
- Particle size: a Laser Diffraction Granulometer (LA950V2, Horiba Ltd., France) is used to determine the size of 
microspheres. A quantity of microspheres is suspended in water, with Tween 80 used as dispersant. The 
average particle size is measured in micrometers. 
 
- Physical appearance: microspheres are examined for their physical appearance by Scanning Electron 
Microscopy (SEM) (LYRA3 XMU, TESCAN, Czech Republic). Microspheres are fixed to a carbon conductive 
tape. A coating of 10 nm of Platinum is applied using a sputter coater. 
 
- Fourier Transform Infrared (FT-IR) study: analysis was carried out on a FT-IR spectrometer (Frontier NIR, 
Perkin Elmer, USA) in order to investigate the possible chemical interactions between the drug and the polymeric 
matrix. Samples were mixed with IR grade KBr salt and pressed into pellets using a manual hydraulic press for 
scanning. 
- In vitro drug release study: The In vitro release study is carried out in PBS solution (0.2 M, pH 7.4). 25 mg 
microspheres are introduced in small vial containing 25 ml PBS, used as release medium, and maintained at 
37°C. At different time intervals, 5 ml of the release medium is withdrawn and replaced with fresh solution. This is 
evaluated for its drug content at 409 nm. 
3.  RESULTS AND DISCUSSION 
Table 2 shows that higher values of DE and DL were observed for formulations with higher PLA ratios, and thus higher 
lactide content in the polymeric mixture. This could be explained by the fact that PLA is more hydrophobic than PLGA due 
to the presence of the side methyl groups, as illustrated in Figure 1 [6,13,14]. As a result, the increased size of 
hydrophobic region facilitates the incorporation of AmB which is hydrophobic in character [15]. In addition, the increase in 
hydrophobicity with increase in lactide content results in better solid-state solubility of AmB in the hydrophobic polymeric 
matrix
12
. These reasons explain the higher DE and DL values for F1 to F3 compared to the other formulations. 
Table 2. % DE, %DL, and average particle size of AmB microspheres formulations 
Formulation 
Code 
%DE %DL 
Size 
(µm) 
F1 23.3 0.66 138 
F2 19.7 0.55 300 
F3 15.6 0.43 233 
F4 16 0.48 173 
F5 10.2 0.45 125 
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Table 1 also gives that the average particle size for the prepared microspheres. It ranges between 125 and 300 µm. This 
indicates that the variation in PLA and PLGA ratios in the polymeric mixture, and thus increasing in lactide content, doesn’t 
have any influence on particle size. It is rather the procedure used and changing the speed of mixing that leaves a direct 
impact on the particle size [16,17]. Moreover, SEM analysis presented in Figure 2 showed mcirospheres that are spherical 
in shape and porous in structure. 
 
Fig 2: SEM photos of microspheres at (a) 100x and (b) 500x magnifications 
Concerning in vitro drug release, Table 3 shows that the release rate is slower for formulations having the highest %DL 
values. These are characterized by a higher burst release after 1 hr 30 min in comparison to the other formulations that 
have a more prolonged or extended release, as shows Figure 3. In addition, the release rate increases as %DL 
decreases. At higher %DL, higher drug quantity requires more time to be released [18,19].  
Table 3. Drug release time of AmB microspheres formulations 
Formulation 
Code 
%DL 
Complete Release  
Time (hrs) 
F1 0.66 30 
F2 0.55 24 
F3 0.43 2 hrs 30 min 
F4 0.48 7 
F5 0.45 5 
 
 
Fig 3: Drug release profile of AmB microspheres formulations 
In additoon, the release rate is directly affected by the ratio of PLA and PLGA in the polymeric mixture. For formulations 
with higher lactide content, they have a slower release rate. This could be explained by the affinity of hydrophobic AmB to 
the more hydrophobic lactide-rich polymer [13,14].  
Besides, polymer characteristics as the solid-state polymer-drug solubility have an influence on drug release and drug 
distribution between the polymeric phase and the aqueous release medium [12]. Higher polymer-drug solubility results in 
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lower release rates. This is due to the higher hydrophobicity of the polymer containing more lactide, and to lower diffusion 
of the hydrophobic drug to the external release medium [20]. 
Lastly, figure 4 reveals the results of polymer-drug physico-chemical compatibility studies. FT-IR spectra were recorded for 
AmB, PLA/PLGA blank microspheres, and PLA/PLGA AmB-loaded microspheres. For PLA/PLGA blank microspheres, 
characteristic peaks are noted at 2900-3000 cm
-1
 for aliphatic C-H stretching, at 1750 cm
-1
, for C=C alkene stretching, at 
1450 cm
-1
 for aliphatic C-H bending, and at 1080-1170 cm
-1
 for C-O ester stretching [21,22]. These peaks are also present 
in the spectrum of loaded microspheres. For AmB, several characteristic peaks appear at 1690 cm
-1
 for C=C alkene, at 
2940 cm
-1
 for C-H  methyl stretching, and the broad bank at 3300-3400 cm
-1
 for –OH alcohol and –NH2 amine groups 
[23,24]. This broad band which is absent in the spectrum of blank polymeric microspheres is present in the case of drug-
loaded microspheres. This indicates the presence of both drug and polymer intact in drug-loaded microspheres and the 
absence of any chemical interaction between the two during microencapsulation procedure. 
 
Fig 4: FT-IR spectra for AmB, PLA/PLGA blank microspheres, and PLA/PLGA AmB-loaded microspheres 
4.  CONCLUSION 
The emuslion solvent evaporation technique is one of the most widespeard and successful methods for preparing drug 
delivery systems based on microspheres ready for oral administration. Polymeric Amphotericin B-loaded microspheres of 
Polylactic acid and Poly(lactid-co-glycolic acid) were formulated by varying the ratio of the two polymers in the organic 
mixture. This factor had a great influence on drug encapsulton and release. As the lactide or polylactic acid content 
increased, Amphotericin B loading and encapsulation also increased. In addition, the drug release was found to be slower 
with more lactide. Particle size obtained was not influenced and was more homogenous for all formulations which is 
expected in the case of solvent evaporation which also yields spherical and porous microspheres. Finally, FT-IR analysis 
revealed that both the drug and the polymeric mixture remained intact following microencapsulation. 
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